Eidogen-Sertanty

Eidogen-Sertanty develops drug discovery software and AI-powered research tools for the pharmaceutical industry. The company offers a suite of knowledgebase and informatics products designed to support researchers working across kinase biology, oncology, and protein target analysis.

Kinase Knowledgebase (KKB)

• The KKB Q4 2025 Release covers 10,270 journal articles and patents.
• Contains 2,949,253 biological activity data points.
• Includes 447,140 unique kinase molecules with annotated assay data.
• Covers 791,020 unique kinase molecules in total from patents and articles, with or without bioactivity data.
• Provides data on 576 unique kinase targets with assay data.
• Features 100,714 annotated assay protocols.

Oncology Knowledgebase (OKB)

• The OKB Q2 2023 Release includes 977 journal articles and patents.
• Contains 146,206 biological activity data points.
• Covers 66,198 molecules sourced from patents and articles.
• Includes data on 1,158 unique oncology targets with assay data.
• Features 5,614 annotated assay protocols.
• Incorporates 137 disease models.

Target Informatics Platform (TIP™)

• Content is updated weekly and includes more than 200,000 high-resolution protein structures.
• Contains approximately 1.2 million annotated co-complex sites and an additional approximately 875,000 predicted sites.
• Covers more than 710,000 protein chains representing every major drug target family.

Eidogen-Sertanty can be contacted directly via phone or email for sales inquiries related to any of its platforms.